JTI-MacDonald Corp rejects CAD 32.5B arbitration proposal

Nov.01.2024
JTI-MacDonald Corp rejects CAD 32.5B arbitration proposal
JTI-Macdonald Corp rejected a CAD 32.5 billion tobacco settlement, citing unresolved issues and uncertainties; Ontario court extended stay to January 31, 2025.

Japan Tobacco International's Canadian subsidiary, JTI-Macdonald Corp, has rejected an arbitration proposal worth 32.5 billion Canadian dollars (23.3 billion U.S. dollars), according to an October 31 Barrons report.

 

The arbitration proposal is aimed at resolving legal disputes stemming from the harm caused by cigarettes, but the company has expressed dissatisfaction and rejected the proposal. Currently, the company is still engaged in complex legal negotiations with provincial governments and smokers.

 

In documents filed with the Ontario Superior Court of Justice before the hearing, the company stated that it is unable to support the agreement due to "key unresolved issues." These issues include the settlement amount and how payments will be distributed among multinational companies.

 

The company stated in court documents that, "This agreement may introduce significant commercial uncertainty and ambiguity in the settlement application of the Canadian tobacco industry. Therefore, JTI-Macdonald and its tobacco company group will not support the current form of the arbitration plan."

 

According to the terms of the agreement, several tobacco companies will pay a total of $32.5 billion Canadian dollars (US$23.3 billion) to settle litigation in Canada.

 

These companies include Philip Morris International (PMI) Canada subsidiary, British American Tobacco (BAT) Canada subsidiary, Imperial Tobacco Canada subsidiary (IMB), and Japan Tobacco International (JTI).

 

The arbitration announced on October 17 will put an end to all claims related to the manufacturing, marketing, selling, using, or handling of tobacco products by these companies. Class action lawsuits against these companies and legal efforts by Canadian provinces to recover medical costs will also be dismissed.

 

The case began in June 2015 when the Quebec Superior Court ordered these three manufacturers to pay billions of dollars in compensation to thousands of Quebec tobacco victims, including smokers or former smokers suffering from emphysema, lung cancer, or throat cancer. In 2019, the ruling was upheld on appeal, prompting the companies to seek creditor protection. Subsequently, a court in Ontario suspended legal proceedings as parties sought to negotiate a settlement.

 

On Thursday, the Ontario Superior Court extended the stay of proceedings until January 31, 2025.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

  South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea Reopens Cigarette Tax Debate as 63% Back Higher Tobacco Taxes
South Korea’s cigarette tax debate has resurfaced after the Ministry of Health and Welfare said tobacco price policy needed review, with a poll showing 63% of respondents support higher tobacco taxes.
Regulations
Jun.22
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
BAT Shares Surge Nearly 6% as FDA Policy Shift Eases Pressure on Vuse and Velo
British American Tobacco (BAT) shares rose sharply on May 12 after the U.S. Food and Drug Administration signaled it would deprioritize enforcement against certain unauthorized e-cigarette and nicotine pouch products with accepted premarket applications. Investors viewed the move as favoring established players such as BAT’s Vuse and Velo brands.
BAT
May.13
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
FDA Defines Enforcement Focus for Unauthorized E-Cigarettes and Nicotine Pouches
The U.S. Food and Drug Administration issued guidance on May 8, 2026, titled “Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization.” The document describes FDA enforcement policies for certain electronic nicotine delivery system products and nicotine pouch products marketed without premarket authorization.
May.09 by 2FIRSTS.ai
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
WHO’s First Global Report on Nicotine Pouches: Harm Reduction Questions Remain Amid Global Regulatory Warning
Ahead of World No Tobacco Day 2026, WHO released its first global report on nicotine pouches, warning that rapid market growth, youth-oriented marketing and weak regulation are converging. 2Firsts views the report as an important warning, but not a complete risk assessment, with harm-reduction questions still unresolved.
Special Report
May.17
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands Reports Q1 2026 Net Sales of $124.3 Million as Modern Oral Net Sales Rise 133%
Turning Point Brands reported first-quarter 2026 results on May 7, covering the period ended March 31, 2026. Total consolidated net sales were $124.3 million, up 16.8% year on year. Gross profit was $68.3 million, up 14.6%, while net income fell 19.0% to $11.7 million. Adjusted EBITDA declined 6.5% to $25.9 million.
May.08 by 2FIRSTS.ai
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Putin Signs Russia’s Tobacco and Nicotine Product Licensing Law, Banning Unlicensed Sales From 2027
Russian President Vladimir Putin has signed a law introducing mandatory licensing for wholesale and retail trade in tobacco and nicotine-containing products, with the system taking effect on October 1, 2026, and unlicensed operations banned from March 1, 2027, while vape and e-liquid retail may also face uncertainty from temporary regional sales-ban powers.
Jul.01